Methotrexate Sodium
Product Images NDC 0054-8550

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Methotrexate Sodium (NDC 0054-8550). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
Chemical structure of the active ingredient methotrexate sodium, showing its molecular framework with nitrogen-containing rings and side chains.*
FDA Label Image

Image 02

Image 02
Methotrexate Tablets USP 2.5 mg label showing 36 tablets. The label includes dosage information, a caution that it is a cytotoxic agent, dispensing instructions for pharmacists, and storage guidance. The labeler is West-Ward Pharmaceuticals Corp., a Hikma company.*
FDA Label Image

Image 03

Image 03
Methotrexate Tablets, USP 2.5 mg unit-dose carton from West-Ward Pharmaceuticals, a Hikma company. The label includes dosage information, warnings such as 'Caution: Cytotoxic Agent,' storage instructions, and indicates the product is for prescription use only. The package contains 1x10 unit-dose tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.